Nuvilex - NVLX
Latest Newsletter Editions Fri, Oct 17, 2014 @ 07:10 am
Hedge Fund Managers- Drowning At Their High Water Marks
It seems like we might have had the capitulation sell off this week, with...
Mon, Jul 21, 2014 @ 06:07 am
Nuvilex (NVLX): Shutting Them Up
It's been the only thing worth covering in July-It's been radio silence from Staffing 360 (STAF...
Sun, Jul 13, 2014 @ 08:07 am
Nuvilex (NVXL): A Tradeable Bottom?
Well, it's July and we're in the middle of the summer doldrums. Microcap stocks are exceptionally...
Fri, May 30, 2014 @ 09:05 am
Nuvilex (NVLX): Don't Be Fooled By Quiet Trading
It's been a rather quiet week on the trading front for Nuvilex (NVLX), but it's anything but quiet on the corporate front.
It's...
Thu, May 1, 2014 @ 09:05 am
Nuvilex (NVLX): Proving My Theory Today
The last edition I published on Nuvilex (NVLX) back on April 19th suggested we had finally...
Click Here For More Newsletters on NVLX | |
Latest Blog Entries |
Quote Data
|
|
Business Summary
Disclosure
MarketBtye LLC was formerly paid a fee of $10,000 and 1 million newly issued restricted shares of Nuvilex by the company for six months of coverage. The 6 months has expired. On November 1, 2013, MarketByte LLC entered into a consulting agreement with Nuvilex to cover the company for an additional 6 months and received 300,00 newly issued restricted shares.
MarketByte LLC currently holds no shares of Nuvilex, and has received $83,155.83 in proceed from sales of NVLX in 2014. At present, MarketByte LLC has no contractual obligation to provide coverage of Nuvilex. Therefore, there are no conflicts of interest.
Recent News Headlines
Fri, 13 Feb 2015 15:54:38 GMT
[at noodls] - PharmaCyte Biotech Diabetes Consortium Member Publishes Review Article on Use of Genetic Engineering to Treat Diabetes
Sat, 31 Jan 2015 07:49:47 GMT
[at noodls] - PharmaCyte Biotech's Partner Austrianova Opens New Facilities in Singapore
Wed, 07 Jan 2015 14:30:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX) today announced that the Company has changed its name to PharmaCyte Biotech, Inc. Shares in PharmaCyte Biotech will trade under the new ticker symbol "PHCB" ...
Tue, 06 Jan 2015 16:45:54 GMT
Tue, 06 Jan 2015 14:30:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX) today announced that its Chief Executive Officer (CEO), Kenneth L Waggoner, JD, and its Chief Operating Officer, Gerald W. Crabtree, Ph.D., will be attending ...
Mon, 22 Dec 2014 15:43:59 GMT
[at noodls] - Share SILVER SPRING, MD, December 22, 2014 (GLOBE NEWSWIRE) - Nuvilex, Inc. (OTCQB: NVLX), a clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, today announced ...
Mon, 22 Dec 2014 13:30:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, today announced that the U.S. Food and Drug Administration ...
Sat, 20 Dec 2014 18:04:13 GMT
Thu, 18 Dec 2014 14:30:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage biotechnology company providing cell and gene therapy solutions for the treatment of diseases, today announced that its partner, Austrianova, ...
Thu, 18 Dec 2014 00:07:34 GMT
Tue, 16 Dec 2014 14:30:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage biotechnology company providing cell solutions for the treatment of diseases, today announced a shareholder update on the Company's cancer ...
Tue, 16 Dec 2014 08:53:31 GMT
[at noodls] - Share SILVER SPRING, MD, December 16, 2014 (GLOBE NEWSWIRE) - Nuvilex, Inc. (OTCQB: NVLX), a clinical-stage biotechnology company providing cell solutions for the treatment of diseases, today announced ...
Wed, 10 Dec 2014 14:30:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, is pleased to provide an update on the significance ...
Mon, 08 Dec 2014 17:17:29 GMT
[at noodls] - Share SILVER SPRING, MD., Dec. 8, 2014 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB: NVLX), a preclinical and clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, ...
Mon, 08 Dec 2014 14:30:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a preclinical and clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, announced today that it has changed ...
Thu, 04 Dec 2014 18:28:46 GMT
[at noodls] - Share SILVER SPRING, MD, December 4, 2014 (GLOBE NEWSWIRE) - Nuvilex, Inc. (OTCQB: NVLX), a clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, announced ...
Thu, 04 Dec 2014 14:30:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, announced today that Nuvilex executives joined Thailand ...
Mon, 01 Dec 2014 16:20:55 GMT
[at noodls] - Share SILVER SPRING, MD, December 1, 2014 (GLOBE NEWSWIRE) - Nuvilex, Inc. (OTCQB: NVLX), a clinical-stage biotechnology company developing cell therapy solutions for the treatment of diseases, announced ...
Mon, 01 Dec 2014 14:30:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage biotechnology company developing cell therapy solutions for the treatment of diseases, announced today that it has obtained an exclusive ...
Mon, 24 Nov 2014 13:30:00 GMT
[GlobeNewswire] - SILVER SPRING, Md. -- Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, announced today that it has formed a "Diabetes ...